Twice Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Twice Therapeutics General Information

Description

Developer of a gene therapy delivery system designed to deliver long-lasting gene therapies to diseased tissues. The company develops a two-step method that can deliver long-lasting gene therapies to diseased tissues without re-engineering viruses, enabling doctors to provide better gene therapy services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Atlanta, GA
  • United States
Primary Industry
Drug Delivery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Atlanta, GA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Twice Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2025 Completed Startup
1. Accelerator/Incubator 20-Aug-2020 Completed Startup
To view Twice Therapeutics’s complete valuation and funding history, request access »

Twice Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
HatchBridge Incubator Accelerator/Incubator
Biolocity Accelerator/Incubator
To view Twice Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Twice Therapeutics FAQs

  • Where is Twice Therapeutics headquartered?

    Twice Therapeutics is headquartered in Atlanta, GA.

  • What industry is Twice Therapeutics in?

    Twice Therapeutics’s primary industry is Drug Delivery.

  • Is Twice Therapeutics a private or public company?

    Twice Therapeutics is a Private company.

  • What is Twice Therapeutics’s current revenue?

    The current revenue for Twice Therapeutics is .

  • Who are Twice Therapeutics’s investors?

    HatchBridge Incubator and Biolocity have invested in Twice Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process